Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …

Simple Summary Bladder cancer (BC) is a common cancer that causes high morbidity and
mortality among affected patients. As a carcinogen-driven cancer, molecular oncology of BC …

Simple Summary Bladder cancer (BCa) is a major urologic malignancy with a high potential
for death-threatening complications. Successful treatment relies on timely diagnostics and …

Simple Summary Bladder cancer (BC) possesses distinct molecular profiles that influence
progression depending on its biological nature and delivered treatment intensity. Muscle …

The global incidence of bladder cancer is more than half a million diagnoses each year.
Bladder cancer can be categorized into non-muscle-invasive bladder cancer (NMIBC) …

Cohesin, a crucial regulator of genome organisation, plays a fundamental role in
maintaining chromatin architecture as well as gene expression. Among its subunits, STAG2 …

Bladder cancer is one of the most common malignancies of the urinary system and has
always presented great challenges in treatment due to its intricate biological features and …

First recognized about 2 hundred years ago, bladder cancer has continued to challenge
both clinicians and researchers due to its inherent heterogeneity in frequent recurrence and …

Die genaue und frühe Klassifikation von nicht-invasiven papillären Urothelkarzinomen der
Harnblase ist essenziell für die Therapieentscheidung und die klinische Prognose der …

非肌层浸润性膀胱肿瘤(NMIBC) 具有较高的发病率和复发率; 给患者带来了极大的不适和经济
负担. 我们对NMIBC 的复发进行了PubMed 文献检索, 本文综述的重点是综合我们目前对与 …